Dr. Christiane Hampe has received a one year pilot research award through the T1D Exchange Biobank Operations Center at the Benaroya Research Institute (BRI) for her project entitled “GAD65Ab: Connecting Type 1 Diabetes and Epilepsy”. This proposal focuses on the investigation of GAD65Ab in T1D-associated epilepsy. The T1D Exchange Biobank Operations Center at BRI was established in 2013 through a grant from The Liona M. and Harry B. Helmsley Charitable Trust. Dr. Hampe is a Research Associate Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition.
Dr. Christiane Hampe has received an award from the National Ataxia Foundation for her project entitled Glutamate Decarboxylase in Cerebellar Ataxia. This one year award investigates the involvement of GAD65 in cerebellar ataxias to better understand the underlying pathogenesis and to design targeted treatment options. Dr. Hampe is a Research Associate Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition.
Dr. Michael Schwartz is author of a recent editorial entitled Can the History of Modern Endocrinology Shape the Future of Obesity? which has been cross-published in all three Endocrine Society journals: Endocrinology, Molecular Endocrinology and the Journal of Clinical Endocrinology and Metabolism. Dr. Schwartz is the RH Williams Endowed Chair in Medicine, Professor, Division of Metabolism, Endocrinology and Nutrition.
Dr. Michael Schwartz has been recognized as one of the most highly influential biomedical researchers in a paper published in the European Journal of Clinical Investigation. The article entitled “A list of highly influential biomedical researchers, 1996-2011“, is based on Scopus citation data and contains a list of 400 core biomedical researchers. Dr. Schwartz is the RH Williams Endowed Chair in Medicine and Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition.
Dr. Michael Schwartz is featured in an interview by the American Society for Clinical Investigation (ASCI), published on September 10, 2014. The focus of The ASCI Interviews series is to provide the American public with a better understanding of how federal taxes support medical advances. Click here for the full transcript of the interview. Dr. Schwartz is the RH Williams Endowed Chair, Director of the Diabetes and Obesity Center of Excellence and a Professor of Medicine in the Division of Metabolism, Endocrinology and Nutrition.
Dr. Joshua Thaler is one of 5 recipients awarded a Pathway to Stop Diabetes Accelerator Award from the American Diabetes Association. This 5-year, $1.625 million grant entitled ” Modulating glial-neuronal interactions to treat obesity and diabetes” explores the possibility that glial cells (the brain’s damage response cells) in the hypothalamus area of the brain play an important part in the process of becoming obese and developing diabetes. Accelerator Awards are granted to early-career diabetes investigators pursuing high risk but promising projects. Dr. Thaler is an Assistant Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition. Click here for more information about this year’s award recipients.
DOCE Associate Director Karin Bornfeldt, PhD is senior author of an article published in the April issue of Cell Reports (Cell Press). This article, entitled “Testing the Role of Myeloid Cell Glucose Flux in Inflammation and Atherosclerosis”, demonstrates that increased glucose flux in macrophages and other myeloid cells does not contribute to inflammation and atherosclerosis in vivo. These findings have important implications for studies on diabetic vascular disease; a multifactorial disease in which the role of glucose is still uncertain. The article was also featured in the April 10th issue of Cell Reports: “Getting to the cardiovascular heart of diabetes: Q&A with Karin Bornfeldt”. DOCE researcher Jenny Kanter, PhD, is co-author on the article.